What is the role of autoimmunity in type 1 diabetes? A clinical perspective (Q38175800)

30 August 2017

title

What is the role of autoimmunity in type 1 diabetes? A clinical perspective (English)

1 reference

30 August 2017

0 references

Marc Y Donath

1

1 reference

30 August 2017

Christoph Hess

series ordinal

2

1 reference

30 August 2017

Ed Palmer

series ordinal

3

1 reference

30 August 2017

publication date

4 January 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

57

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

653-655

1 reference

The diagnosis of insulitis in human type 1 diabetes.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Screening for insulitis in adult autoantibody-positive organ donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Analysis of islet inflammation in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Beta-cell replication is increased in donor organs from young patients after prolonged life support

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Advances in human antiglomerular basement membrane disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Biomarkers and immune-modulating therapies for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Genetics of type 1A diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Recurrence of disease in pancreas transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3153-0

Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24389751

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24389751

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-013-3153-0

1 reference

Dimensions Publication ID

30 August 2017

1044308264

0 references

1 reference